WQ3 Stock Overview
Provides genetic diagnostic solutions in Poland. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
HyEnergy S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł0.49 |
52 Week High | zł0.75 |
52 Week Low | zł0.27 |
Beta | 1.27 |
1 Month Change | 6.03% |
3 Month Change | n/a |
1 Year Change | 0% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -88.82% |
Recent News & Updates
Recent updates
Shareholder Returns
WQ3 | DE Life Sciences | DE Market | |
---|---|---|---|
7D | 24.2% | -0.5% | -0.1% |
1Y | 0% | -2.8% | 7.4% |
Return vs Industry: WQ3 exceeded the German Life Sciences industry which returned -2.8% over the past year.
Return vs Market: WQ3 underperformed the German Market which returned 7.4% over the past year.
Price Volatility
WQ3 volatility | |
---|---|
WQ3 Average Weekly Movement | 11.8% |
Life Sciences Industry Average Movement | 7.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: WQ3's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: WQ3's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 8 | n/a | www.inno-gene.pl |
HyEnergy S.A. provides genetic diagnostic solutions in Poland. It is involved in the research and diagnostic center implementation; and the provision of technologies in the field of DNA analysis. The company also develops and implements diagnostic algorithm for prevention and personalization of treatment of HPV-dependent solid tumors.
HyEnergy S.A. Fundamentals Summary
WQ3 fundamental statistics | |
---|---|
Market cap | €23.61m |
Earnings (TTM) | -€1.38m |
Revenue (TTM) | €85.83k |
275.1x
P/S Ratio-17.0x
P/E RatioIs WQ3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WQ3 income statement (TTM) | |
---|---|
Revenue | zł365.00k |
Cost of Revenue | zł681.00k |
Gross Profit | -zł316.00k |
Other Expenses | zł5.57m |
Earnings | -zł5.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.18 |
Gross Margin | -86.58% |
Net Profit Margin | -1,613.42% |
Debt/Equity Ratio | 31.0% |
How did WQ3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/06 02:29 |
End of Day Share Price | 2025/01/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HyEnergy S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Adrian Kowollik | East Value Research GmbH |